Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Rutherford

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Pharmacoeconomics|July 5, 2024
Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to KnowNicholas R Latimer, Mark J Rutherford
BMC Medical Research Methodology|March 30, 2022
Immortal time bias for life-long conditions in retrospective observational studies using electronic health recordsFreya Tyrer, Krishnan Bhaskaran, Mark J Rutherford
Journal of Intellectual & Developmental Disability|January 17, 2025
Mortality, predictors and causes among people with intellectual disabilities: A systematic narrative review supplemented by machine learningFreya Tyrer, Reza Kiani, Mark J Rutherford
Statistics in Medicine|September 15, 2021
Inverse probability weighting and doubly robust standardization in the relative survival frameworkElisavet Syriopoulou, Mark J Rutherford, Paul C Lambert
BMC Medical Research Methodology|June 23, 2022
Generating high-fidelity synthetic time-to-event datasets to improve data transparency and accessibilityAiden Smith, Paul C Lambert, Mark J Rutherford
Cancer Epidemiology|July 1, 2026
Can we develop prognostic models for estimating life expectancy following a cancer diagnosis? Evaluating model complexity, data requirements, and optimal modelling frameworksHannah L Cooper, Mark J Rutherford, Sarah Booth
Biometrical Journal. Biometrische Zeitschrift|December 14, 2020
Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival frameworkElisavet Syriopoulou, Mark J Rutherford, Paul C Lambert
Cancer Epidemiology|August 17, 2023
Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-setsMolly Wells, Mark J Rutherford, Paul C Lambert
International Journal of Epidemiology|January 19, 2020
Marginal measures and causal effects using the relative survival frameworkElisavet Syriopoulou, Mark J Rutherford, Paul C Lambert
Cancer Epidemiology|December 28, 2016
Assessment of lead-time bias in estimates of relative survival for breast cancerTherese M-L Andersson, Mark J Rutherford, Keith Humphreys
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Pharmacoeconomics|July 5, 2024
Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to KnowNicholas R Latimer, Mark J Rutherford
BMC Medical Research Methodology|March 30, 2022
Immortal time bias for life-long conditions in retrospective observational studies using electronic health recordsFreya Tyrer, Krishnan Bhaskaran, Mark J Rutherford
Journal of Intellectual & Developmental Disability|January 17, 2025
Mortality, predictors and causes among people with intellectual disabilities: A systematic narrative review supplemented by machine learningFreya Tyrer, Reza Kiani, Mark J Rutherford
Statistics in Medicine|September 15, 2021
Inverse probability weighting and doubly robust standardization in the relative survival frameworkElisavet Syriopoulou, Mark J Rutherford, Paul C Lambert
BMC Medical Research Methodology|June 23, 2022
Generating high-fidelity synthetic time-to-event datasets to improve data transparency and accessibilityAiden Smith, Paul C Lambert, Mark J Rutherford
Cancer Epidemiology|July 1, 2026
Can we develop prognostic models for estimating life expectancy following a cancer diagnosis? Evaluating model complexity, data requirements, and optimal modelling frameworksHannah L Cooper, Mark J Rutherford, Sarah Booth
Biometrical Journal. Biometrische Zeitschrift|December 14, 2020
Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival frameworkElisavet Syriopoulou, Mark J Rutherford, Paul C Lambert
Cancer Epidemiology|August 17, 2023
Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-setsMolly Wells, Mark J Rutherford, Paul C Lambert
International Journal of Epidemiology|January 19, 2020
Marginal measures and causal effects using the relative survival frameworkElisavet Syriopoulou, Mark J Rutherford, Paul C Lambert
Cancer Epidemiology|December 28, 2016
Assessment of lead-time bias in estimates of relative survival for breast cancerTherese M-L Andersson, Mark J Rutherford, Keith Humphreys
Pageof 8